- Category
- Micro (2020-21)
- Udyam number
- UDYAM-TS-31-0001308

Anegan Pharmaceuticals Private Limited
About Anegan Pharmaceuticals Private Limited
Data last updated:
Anegan Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the instruments and appliances for measuring segment of the healthcare sector. It was incorporated on 19 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U33120TG2020PTC146080. Its GSTIN is 36AAUCA3993M1ZQ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Nagaraju Nuguri (Managing Director) and Parsa Saritha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.77 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.19 Lakh (net margin 2.7%) and EBITDA of ₹1.19 Lakh (EBITDA margin 2.7%). Revenue has grown at a compounded annual rate (CAGR) of 194% over three years.
Anegan Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-31-0001308).
Company details
Recognitions & Rankings of Anegan Pharmaceuticals
Contact details
Anegan Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressH.No. 30 – 239/2/7 P.No.38/B, Dwarakamai Colony Old Safilguda Medchal – Malkajgir, Hyderabad, Telangana, India – 500056
- IndustryHealthcare, Instruments And Appliances For Measuring, Manufacturing, Checking, Medical Appliances And Instruments
To see the full contact details of Anegan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anegan Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Anegan Pharmaceuticals Private Limited, buy the company report.
Financials of Anegan Pharmaceuticals Private Limited
FY 2025 filings availableAnegan Pharmaceuticals Private Limited reported revenue of ₹43.77 Lakh (up 1190% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 194% over three years. EBITDA rose 242% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.19 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anegan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anegan Pharmaceuticals Private Limited
Anegan Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagaraju Nuguri | Managing Director | 18 Jul 2024 | 2 Years 3 Months | Current |
| Parsa Saritha | Director | 24 Feb 2025 | 1 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Anegan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anegan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Anegan Pharmaceuticals Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Anegan Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAUCA3993M1ZQ | Telangana | Active | 23 Jan 2021 |
To see the full GST registrations and return filing status of Anegan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anegan Pharmaceuticals Private Limited has 6 board changes on record since 2024: 3 appointments and 3 cessations. The latest: Parsa Saritha was appointed as Director on 24 Feb 2025.
Frequently asked questions
Anegan Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in instruments and appliances for measuring, within the healthcare industry. It was incorporated on 19 November 2020 (6+ years old) and is registered under CIN U33120TG2020PTC146080.
Anegan Pharmaceuticals has 2 current directors:
- Nagaraju Nuguri - Managing Director
- Parsa Saritha - Director
The latest financial statements of Anegan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Anegan Pharmaceuticals is 36AAUCA3993M1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Anegan Pharmaceuticals is U33120TG2020PTC146080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anegan Pharmaceuticals was incorporated on 19 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Parsa Saritha was appointed as Director on 24 Feb 2025. Selva Preethi ceased to be Director on 24 Feb 2025. Nikhil Thopucharla ceased to be Managing Director on 30 Aug 2024. Anegan Pharmaceuticals has 6 board changes on record in total.
Yes, Anegan Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-31-0001308).
The registered office of Anegan Pharmaceuticals is at H.No. 30 – 23927 P.No.38B, Dwarakamai Colony Old Safilguda Medchal – Malkajgir, Hyderabad, Telangana, India – 500056.
Anegan Pharmaceuticals operates in the healthcare industry, in the instruments and appliances for measuring segment.

